Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
2.51T | 1.43T | 1.85T | 1.58T | 1.61T | 1.50T | Gross Profit |
1.69T | 1.43T | 1.29T | 989.30B | 964.98B | 825.68B | EBIT |
637.61B | 615.08B | 472.55B | 265.38B | 203.64B | 112.25B | EBITDA |
637.61B | 635.04B | 488.90B | 280.08B | 218.35B | 125.95B | Net Income Common Stockholders |
453.16B | 442.56B | 340.37B | 251.10B | 183.84B | 95.66B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
1.35T | 1.90T | 1.64T | 2.14T | 1.82T | 1.60T | Total Assets |
24.07T | 23.64T | 19.58T | 17.53T | 15.74T | 13.77T | Total Debt |
2.06T | 2.01T | 1.84T | 1.59T | 1.40T | 1.99T | Net Debt |
715.24B | 108.69B | 199.42B | -550.53B | -412.70B | 397.46B | Total Liabilities |
21.20T | 20.94T | 17.37T | 15.65T | 14.07T | 12.48T | Stockholders Equity |
2.73T | 2.56T | 2.14T | 1.82T | 1.58T | 1.23T |
Cash Flow | Free Cash Flow | ||||
0.00 | 1.54T | -62.39B | 562.51B | 1.36T | 776.91B | Operating Cash Flow |
0.00 | 1.57T | -37.71B | 581.11B | 1.38T | 795.65B | Investing Cash Flow |
0.00 | -1.46T | -680.05B | -393.21B | -629.87B | -423.08B | Financing Cash Flow |
0.00 | 2.47T | 247.91B | 174.51B | -546.67B | 29.92B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $118.80B | 19.51 | 17.89% | 0.71% | 22.15% | 12.13% | |
74 Outperform | $65.92B | 9.31 | 20.65% | 8.28% | -6.74% | 5.13% | |
73 Outperform | $176.27B | 23.24 | 14.51% | 0.78% | 13.13% | 0.54% | |
72 Outperform | $61.71B | 12.86 | 8.73% | 5.02% | -2.65% | -14.84% | |
70 Outperform | $29.13B | 9.43 | 10.61% | 0.85% | -9.78% | 27.43% | |
70 Outperform | $20.43B | 16.92 | 10.89% | 4.99% | -3.94% | 31.52% | |
65 Neutral | $12.93B | 9.81 | 7.84% | 78.03% | 12.20% | -7.74% |